Tumor characteristics involved in the metastatic behaviour as an improvement in primary cutaneous melanoma prognostics

Journal of Experimental and Clinical Cancer Research

Volumn 17, Issue 4, 1998, Pages 483-489

  Goldmann, T ^a,c   Ribbert, D ^b   Suter, L ^a   Brode, M ^a   Otto, F ^a  

^a Fachklinik Hornheide   (Germany)

^b Inst F Allg Zoologie und Genetik   (Germany)

^c RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Immunohistochemistry; Melanoma; Metastasis; Prognosis; Statistics

Indexed keywords

CATHEPSIN B; CATHEPSIN D; COLLAGENASE; CYCLINE; METALLOTHIONEIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SKIN ULCER; THICKNESS;

FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; PEPTIDE HYDROLASES; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032434630     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Burton, R.C., Coates, M.S., Hersey, P., Roberts, G., Chetty, M.P., Chen, S., Hayes, M.H., Howe, C.G., Armstrong, B.K., An analysis of a melanoma epidemic. Int. J. of Cancer 55: 765-770. 1993.
2. Garbe, Cl. Stadler, R., Orfanos, C.E., Prognose-orientierte Therapie beim malignen Melanom. Der Hautarzt 37: 365-372. 1986.
3. Bartkowiak, D., Schumannn, J., Otto, F.J., Lippold, A., Drepper, H. DNA Flow Cytometry in the Prognosis of Primary Malignant Melanoma. Oncology 48: 39-43. 1991.
4. Drepper, H., Grootens, A., Padberg, G., Peters, A., Wiebelt, H., Prognoserelevante Kriterien und stadiengerechte Therapie des malignen Melanoms. In: Fortschritte der Kiefer- und Gesichts-Chirurgie. Stuttgart, New York : G. Thieme Verl. 1988: 143-148.
5. Liotta, L.A., Stetler Stevenson, W.G., Tumor Invasion and Metastasis: An Imbalance of Positive and Negative Regulation. Cancer Research (Suppl.) 51: 5040-5049. 1991.
6. Fidler, I.J., The Biology of Melanoma Metastasis. J. Dermatol. Surg. Oncol. 14: 875-881. 1988.
7. Schmoeckel, Ch., Braun-Falco, O., Prognostic index in malignant melanoma. Arch. Dermatol. 114: 871-873. 1978.
8. Kirschke, H., Barret, A.J., Chemistry of lysosomal proteases. In: Lysosomes. Their Role in Protein Breakdown. London: Academic Press, 1987: 193-238.
9. Mort, J.S., Leduc, M., Recklies, A.D., A latent thiol proteinase from ascites fluid of patients with neoplasia. Biochim. Biophys. Acta 662: 173-180. 1981.
10. Qian, F., Chan, S.J., Achkar, C., Steiner, D.F., Frankfater, A., Transcriptional regulation of cathepsin B expression in B16 melanomas of varying metastatic potential. Biochem. Biophys. Res. Commun. 202: 429-436. 1994.
11. Honn, K.V., Timar, J., Bazaz, R., Sameni, M., Ziegler, G., Sloane, B.F., A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells. Exp. Cell. Res. 214: 120-130. 1994.
12. Chan, S.J., San-Segundo, B., McCormik, M.B., Steiner, D.F., Nucleotide and predicted amino acid sequences of cloned human and mouse preprocathepsin B cDNAs. Proc. Natl. Acad. Sci. USA 83: 7721-7725. 1986.
13. Rochefort, H., Augerau, P., Briozzo, P., Capony, F., Cavailles, V., Freiss, G., Garcia, M., Maudelonde, T., Morisset, M., Vignon, F., Structure, function, regulation and clinical significance of the 52 kD pro-cathepsin D secreted by breast cancer cells. Biochimie 10: 943-949. 1988.
14. Briozzo, P., Morisset, M., Capony, F., Rougeot, C., Rochefort, H., In vitro degradation of extracellular matrix with 52,000 cathepsin D secreted by breast cancer cells. Cancer Res. 18: 3688-3692. 1988.
15. Leto, G., Gebbia, N., Rausa, L., Tumminello, F.M., Cathepsin D in the malignant progression of neoplastic diseases. Anticancer Res. 12: 235-240. 1992.
16. Sivestrini, R., Veneroni, S., Benini, E., Di Fronzo, G., Daidone, M.G., p53 and cathepsin D are independent of established prognostic factors in breast cancer. Int. J. Oncol. 1: 507-512. 1992.
17. Maudelonde, T., Khalaf, S., Garcia, M., Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: Low correlation with other prognostic parameters. Cancer Res. 48: 462-466. 1988.
18. Liotta, L.A., Tryggvason, K., Garbisa, S., Robey, P.G., Abe, S., Partial purification and characterization of a neutral protease which cleaves type IV collagen. Biochemistry 20: 100-108. 1981.
19. Cottam, D.W., Rees, R.C., Regulation of matrix metalloproteinases: their role in tumor invasion and metastasis. International Journal of Oncology 2: 861-872. 1993.
20. Stetler-Stevenson, W.G., Krutzsch, H.C., Wacher, M.P., Margulies, I.M.K., Liotta, L.A., The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. J. Biol. Chem. 264: 1353-1356. 1989.
21. Monteagudo, C., Merino, M.J., San-Juan, J., Liotta, L.A., Stetler-Stevenson, W.G., Immunhistochemical Distribution of Type IV Collagenase in Normal, Benign and Malignant Breast Tissue. Am. J. Pathology 136: 585-592. 1990.
22. Wang, M., Stearns, M.E., Blocking of Collagenase IV Secretion by Estramustine during in Vitro Tumor Cell Invasion. Cancer Res. 48: 6262-6271. 1988.
23. Klaasen, C.D., Adamson, R.H., Andrews, G.K., Beyersmann, D., Butt, T.R., Cherian, M.G., Choudhuri, S., Coogan, T.P., Cousins, R.J., et al., National Cancer Institute Workshop on the Possible Roles of Metallothionein in Carcinogenesis. Cancer Res. 53: 922-925. 1993.
24. Zelger, B., Hittmair, A., Schir, M., Öfner, C., Fritsch, P.O., Böcker, W., Jasani, B., Schmid, K.W., Immunohistochemically demonstrated metallothionein expression in malignant melanoma. Histopathology 23: 257-264. 1993.
25. Coltrera, M.D., Gown, A.M., PCNA / Cyclin and BrdU Uptake Define Different Subpopulations in Different Cell Lines. J. Histochem. Cytochem. 39: 23-30. 1991.
26. Takahashi, H., Strutton, G.M., Parsons, P.G., Determination of the proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody. Histopathology 18: 221-227. 1991.
27. Girod, S.C., Groth, W., Junk, M., Gerlach, X.L., p53 and PC-NA expression in malignant melanomas of the head and neck. Pigment Cell Res. 7: 354-357. 1994.
28. Duffy, M.J., Do proteases play a role in cancer invasion and metastasis? European Journal of Cancer & Clinical Oncology 23: 583-589. 1987.
29. Breslow, A., Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann. Surg. 172: 902-908. 1970.
30. Cordell, J.L., Falini, B., Erber, W.N., Gosh, A.K., Abdulaziz, Z., MacDonald, S., Pulford, K.A., Stein, H., Mason, D.Y., Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase. J. Histochem. Cytochem. 32: 219-229. 1984.
31. Spiegel, M.R., Statistik (2nd edition). Hamburg: McGraw-Hill Book Company, 1990.
32. Sachs, L., Angewandte Statistik (6th edition). Berlin, Heidelberg, New York: Springer-Verlag, 1984.
33. Hermanek, P., Scheibe, O., Spiessl, B., Wagner, G., UICC, International Union against Cancer, TNM, Klassifikation maligner Tumoren. Berlin, Heidelberg, New York: Springer-Verlag, 1987: 95-98.
34. Balch, C.M., Seng-Jaw, S. : Treatment of skin cancer using multiple modalities. J. Acad. Dermatol. 7: 143. 1983.
35. Monden, N., Abe, S., Sutoh, I., Hishikawa, Y., Kinugasa, S., Nagasue, N., Prognostic significance of the expressions of metallothionein, glutathione-S-transferase-pi, and P-glycoprotein in curatively resected gastric cancer. Oncology 54: 391-399. 1997.
36. Hishikawa, Y., Abe, S., Kinugasa, S., Yoshimura, H., Monden, N., Igarashi, M., Tachinaba, M., Naguse, N., Overexpression of metallothionein correlates with chemoresistance to cisplatin and prognosis in esophageal cancer. Oncology 54: 342-347. 1997.
37. Uozaki, H., Horiuchi, H., Ishida, T., Iijima, T., Imamura, T., Machinami, R., Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis. Cancer 79: 2336-2344. 1997.
38. Ohshio, G., Imamura, T., Okada, N., Wang, Z.H., Yamaki, K., Kyogoku, T., Suwa, H., Yamabe, H., Imamura, M., Immunohistochemical study of metallothionein in pancreatic carcinomas. J. Cancer Res. Clin. Oncol. 122: 351-355. 1996.
39. Goulding, H., Jasani, B., Pereira, H., Reid, A., Galea, M., Bell, J.A., Elston, C.W., Robertson, J.F., Blamey, R.W., Nicholson, R.A., et al., Metallothionein expression in human breast cancer. Br. J. Cancer 72: 968-972. 1995.
40. Öfner, D., Maier, H., Riedmann, B., Bammer, T., Rumer, A., Winde, G., Böcker, W., Jasani, B., Schmid, K.W., Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival. Virchows Arch. 425: 491-497. 1994.
41. Germain, I., Tetu, B., Brisson, J., Mondor, M., Cherian, M.G., markers of chemoresistance in ovarian carcinomas: an immunohistochemical study of 86 cases. Int. J. Gynecol. Pathol. 15: 54-62. 1996.
42. Sauerbrey, A., Zintl, F., Volm, M., Expression of metallothionein in initial and relapsed childhood acute lymphoblastic leukemia. Ann. Hematol. 69: 111-115. 1994.
43. Haitel, A., Wiener, H.G., Migschitz, B., Marberger, M., Susani, M., Proliferating cell nuclear antigen and MIB-1. An alternative to classic prognostic indicators in renal cell carcinomas? Am. J. Clin. Pathol. 197: 229-235. 1997.
44. Colvett, KT., Hsu, D.W., Su, M., Lingood, R.M., Pardo, F.S., High PCNA index in meningiomas resistant to radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 38: 263-468. 1997.
45. Visani, G., Ottaviani, E., Danova, M., Mangiarotti, R., Tosi, P., Tura, S., The expression of proliferation and quiescence associated antigens in acute myeloid leukemia correlates with survival duration: analysis of 25 refractory cases. Haematologica 82: 338-340. 1997.
46. Sheen-Chen, S.M., Eng, H.L., Chou, F.F., Chen, W.J., the prognostic significance of proliferating cell nuclear antigen in patients with lymph node-positive breast cancer. Arch. Surg. 132: 264-267. 1997.
47. Inagaki, T., Ebisuno, S., Uekado, Y., Hirano, A., Hiroi, A., Shinka, T., Ohkawa, T., PCNA and p53 in urinary bladder cancer: correlation with histological findings and prognosis. Int. J. Urol. 4: 172-177. 1997.
48. Kanitakis, J., Narvaez, D., Euvrard, S., Faure, M., Claudy, A., proliferation markers Ki67 and PCNA in cutaneous squamous cell carcinomas: lack of prognostic value. Br. J. Dermatol. 136: 643-644. 1997.
49. Sommer, T., Olofsson J., Significance of p53, PCNA and Ki67 in the prognosis of squamous cell carcinoma of the oral cavity. Laryngorhinootologie 76: 189-196. 1997.
50. Allgayer, H., Babic, R., Grutzner, K.U., Tarabichi, A., Wilhelm Schildberg, F., Heiss, M..M., An immunohistochemical assessment of cathepsin D in gastric carcinoma: its impact on clinical prognosis. Cancer 80: 179-187. 1997.
51. Suter, L., Bröcker, E.B., Ostmeier, H., Schumann, J., Sorg, Cl., Metastatic human melanoma. Phenotypic heterogeneity and antigen expression in relation to the clinical status. J. Cancer Res. Cli. Oncol. 115: 459-464. 1989.